Can IxMP Be Used as a Second or Third-Line Chemotherapy for Metastatic Castrate Resistant Prostate Cancer? There was a report recently released about a Phase 2 study from the Department of Defense funded Prostate Cancer Clinical Trials Consortium that suggests that ixabepilone + mitoxantrone + prednisone may have clinically significant activity as a form of [...]
There is some good budgetary news as it now appears that the CDMRP (the Department of Defense) programs, including the Peer Reviewed Prostate Cancer Program, are funded at the omnibus level (last year’s level). The bill has not yet passed and is still vulnerable to changes. As of today, this is how the budget looks: [...]
Getting increased funding for the Department of Defense (DOD) Peer Review Prostate Cancer Research Program (PCRP) is one of the goals that have been identified by a coalition of many of the prostate cancer advocacy and support organizations. The funding for the program has remained stagnant for a number of years despite the fact that [...]
Yesterday afternoon I participated in a conference call, which included representatives from most of the major prostate cancer organizations in the United States. Alvin Chin and John Willey who serve as consumer advocates for the Department of Defense Congressionally Directed Medical Research programs (DOD CDMRP) prompted the call. Alvin and John serve specifically on the [...]